Resectable pancreas adenocarcinoma: the longer the wait time, the longer the oncologic survival?

HPB (Oxford). 2020 May;22(5):789. doi: 10.1016/j.hpb.2020.01.015. Epub 2020 Feb 9.

Authors

Zheng-Liang Chen¹, Tian Yang², Ying-Jian Liang³

Affiliations

¹ Department of Hepatobiliary Surgery, The First Affiliated Hospital of Harbin Medical University, Heilongjiang, China.
² Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
³ Department of Hepatobiliary Surgery, The First Affiliated Hospital of Harbin Medical University, Heilongjiang, China. Electronic address: genomeliang@hotmail.com.

PMID: 32051091
DOI: 10.1016/j.hpb.2020.01.015

No abstract available

Publication types

Letter
Comment

MeSH terms

Adenocarcinoma* / surgery
Humans
Pancreas
Pancreatic Neoplasms* / surgery
Waiting Lists